National Bank Financial upgraded shares of Extendicare (TSE:EXE - Free Report) to a strong-buy rating in a report released on Wednesday morning,Zacks.com reports.
Several other equities research analysts have also weighed in on the company. TD Securities upped their price objective on Extendicare from C$13.00 to C$15.00 and gave the company a "hold" rating in a research note on Thursday, May 22nd. National Bankshares set a C$15.40 price objective on Extendicare and gave the company an "outperform" rating in a research note on Thursday. Finally, BMO Capital Markets increased their price target on Extendicare from C$13.50 to C$14.50 in a research report on Monday, May 12th. Three investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of C$13.98.
View Our Latest Analysis on Extendicare
Extendicare Price Performance
Shares of EXE stock traded down C$0.32 during trading hours on Wednesday, hitting C$12.91. The company had a trading volume of 208,903 shares, compared to its average volume of 185,060. Extendicare has a 12 month low of C$7.34 and a 12 month high of C$15.24. The firm has a market capitalization of C$1.08 billion, a price-to-earnings ratio of 16.46 and a beta of 1.26. The firm's fifty day moving average is C$14.03 and its 200 day moving average is C$12.76. The company has a debt-to-equity ratio of 283.02, a quick ratio of 0.98 and a current ratio of 0.62.
Extendicare Announces Dividend
The firm also recently declared a jul 25 dividend, which will be paid on Friday, August 15th. Investors of record on Friday, August 15th will be given a dividend of $0.042 per share. The ex-dividend date of this dividend is Thursday, July 31st. This represents a yield of 3.81%. Extendicare's dividend payout ratio (DPR) is presently 61.20%.
Extendicare Company Profile
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Further Reading

Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.